Leerink Swann Initiates Fate Therapeutics With Outperform
June 01, 2015 at 08:26 AM EDT
Leerink Swann initiated coverage on Fate Therapeutics Inc (NASDAQ: FATE) with a Outperform rating. The target price for Fate ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.